A preparation method for synthesizing pyrimidinedione compounds
By employing a three-step synthesis process involving hydrogenation-reduction reaction-amine ester exchange reaction-cyclization reaction, the problems of long preparation routes, complex processes, and high costs associated with compound V have been solved. This process achieves efficient purification and high yield of compound V, making it suitable for industrial production.
Patent Information
- Application Number
- CN202211414763.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-11-11
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2042-11-11
AI Technical Summary
The current methods for preparing compound V involve long synthetic routes, complex processes, difficult-to-obtain starting materials, high costs, and the generation of a large number of reaction byproducts. They also fail to guarantee the purification of compound V, resulting in low yields that do not meet the requirements for industrial production.
A three-step synthetic process of hydrogenation-reduction reaction-amine ester exchange reaction-cyclization reaction is adopted, using inexpensive and readily available benzonitrile compounds as starting materials. The synthetic route is simplified, impurity generation is suppressed, and yield is improved by the action of metal catalysts and anhydrous acid.
This method effectively simplifies the synthesis process of pyrimidine dione compounds, reduces costs, increases yield, meets the requirements of industrial production, and ensures the purification of the compounds.
Smart Images

Figure QLYQS_1
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of chemical pharmacy, and specifically relates to a preparation method for synthesizing pyrimidinedione compounds. Background Art
[0002] The production process of chemical drugs consists of two parts: raw material production and pharmaceutical preparation production. Among them, synthetic pyrimidine dione compounds are widely used as pharmaceutical preparations as key intermediates of Elagolix Sodium, Elagolix Sodium (Elagolix Soidum), CAS registration number: 832720-36-2, structural formula: It is a novel, potent, selective, orally active non-peptide antagonist of gonadotropin-releasing hormone receptor (GnRHR) with a Kd value of 54pM. At a concentration of 10μM, it has no significant activity on ion channels, enzymes, and transporters.
[0003] Globally, nearly 200 million women suffer from endometriosis, and the incidence is clearly on the rise. The age of onset is mostly between 30 and 49 years old. The incidence rate among women of childbearing age is as high as 15%, accounting for about 70% to 80% of infertility patients, seriously affecting women's physical and mental health, work and fertility. The cause of the disease is not clear. It is reported that it may be related to immune, genetic, vascular, estrogen and its receptors and other factors. At present, the treatment method for this disease is mainly oral active non-peptide gonadotropin-releasing hormone (GnRHR) antagonists, which are used to treat endometriosis. As a key intermediate of elagrocaprine sodium, 1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione (i.e., compound V, with the structural formula , CAS registration number: 830346-47-9). The patents currently reporting the synthesis process of compound V are as follows: such as WO2019 / 112968, WO2021214318, etc., using 3-fluorotrifluorotoluene as a raw material, first using n-butyl lithium / DMF system to obtain 2-fluoro-6-trifluoromethylbenzaldehyde, and then through a series of reactions such as oximation reaction and reduction to obtain the product. The specific synthesis route is as follows:
[0004] ,
[0005] Although the starting materials of this synthetic route are simple and easily available, the reaction steps are lengthy, column purification is required, the process is complicated, the overall yield is low, and it is not suitable for industrial production.
[0006] At present, the literature reporting the preparation method of compound V is as follows: Patents WO2005 / 7164, US7056927, US7419983B2, CN1819829A, etc. report that 2-fluoro-6-trifluoromethylbenzonitrile is used as the starting material, borane is used to reduce the cyano group, and then reacted with urea and hydrochloric acid to obtain a urea compound, and then urea and diketene are cyclized under the condition of sodium iodide to obtain the key intermediate of GnRHR drug. The public route is as follows:
[0007] ,
[0008] This route uses the explosive and toxic controlled product diketene, and uses borane as a cyanide reducing agent, which is highly toxic and flammable, unfriendly to the environment, highly dangerous, has a high production safety risk, and is not suitable for industrial production;
[0009] For example, patents WO2009 / 62087, WO2018198086A1, WO2021 / 130776, etc. report another route, and the specific synthesis route is as follows:
[0010] ,
[0011] This route uses tert-butyl acetoacetate to replace diketene in the previous route for the ring-closing reaction, but this route has a long reaction time and high temperature, and produces a large amount of compound IV. It is difficult to purify the IV-impurity impurities in compound IV. The resulting product contains a large amount of V-impurity impurities, which are difficult to purify, and the yield is about 50%.
[0012] In summary, the current preparation method of Compound V has a long synthetic route, a complex synthetic process, difficult to obtain starting materials, high cost, a large number of reaction by-products, and cannot guarantee the purification of Compound V. The yield is low and cannot meet the requirements of industrial production. Summary of the invention
[0013] The object of the present invention is to provide a method for preparing a synthetic pyrimidinedione compound, so as to solve the problems that the current method for preparing compound V proposed in the above background technology has a long synthesis route, a complex synthesis process, difficulty in obtaining starting raw materials, high cost, a large amount of reaction by-products, inability to ensure the purification of compound V, low yield, and cannot meet the requirements of industrial production.
[0014] To achieve the above object, the present invention provides the following technical solution: a method for preparing a pyrimidinedione compound, the specific synthesis route is as follows:
[0015] ;
[0016] Among them, compound I is used as a raw material to undergo a hydrogenation reduction reaction under the action of a metal catalyst to obtain intermediate II, intermediate II and compound III undergo an amine ester exchange reaction to achieve the preparation of intermediate IV, and intermediate IV undergoes a cyclization reaction under anhydrous acid conditions to achieve the preparation of target compound V.
[0017] The specific synthesis steps of compound V prepared according to the above synthesis route are as follows:
[0018] S1. Preparation of intermediate II: Compound I is used as a starting material for the reaction, and is directly put into a hydrogenation reactor, and a hydrogenation reduction reaction is carried out at 20 to 100° C. in an organic solvent and an atmosphere of a reducing agent at a pressure of 0.1 to 2 MPa under the action of a metal catalyst of 0.1 to 20% by weight of compound I and ammonia water, and the intermediate II is obtained by treatment and concentration, wherein the metal catalyst is Ranney-Ni, compound I is one of benzonitrile, 2,4,6-trifluorobenzonitrile, 2-fluoro-6-(trifluoromethyl)benzonitrile, 2-fluoro-6-chlorobenzonitrile, p-cyanotoluene, 2,6-dichlorobenzonitrile, 5-bromo-2-(trifluoromethoxy)benzonitrile, the organic solvent is one of methanol, ethanol, tetrahydrofuran, N,N-dimethylacetamide, acetone, acetonitrile, ethylene glycol, dimethyl sulfoxide, 1,4-dioxane or a mixture of several thereof; the reducing agent is one of H2, NaBH4, NaBH3CN, Zn or HCL;
[0019] S2, preparation of intermediate IV: intermediate II obtained in S1 and compound III are mixed in a furan solvent at a molar ratio of 1:1.0-6.0, strong base and weak acid salt organic base are added at room temperature to carry out amine ester exchange reaction at 0-70°C, concentrated, washed with water, and then slurried with ethanol to obtain intermediate IV, wherein compound III is one of (3-oxobutyl)-ethyl carbamate, (3-oxobutyl)-methyl carbamate, and 2,4-dioxopiperidine-1-carboxylic acid benzyl ester, the furan solvent is one of dimethylformamide, dimethyl sulfoxide, tetrahydrofuran, acetonitrile, 1,4-dioxane, dimethylacetamide or a mixture thereof, and the strong base and weak acid salt organic base is one of sodium methoxide, sodium ethoxide, and sodium hydride;
[0020] S3. Preparation of compound V: The intermediate IV obtained in S2 is stirred in a reaction solvent, and refluxed with water under anhydrous acid conditions, and then a cyclization reaction is carried out at 20-150°C for 1-10 hours, and then purified with isopropanol to obtain the target compound V, wherein the molar ratio of the intermediate IV to the anhydrous acid is 1:0.1-3.0, the anhydrous acid is one or a mixture of thionyl chloride, glacial acetic acid, nitric acid, sulfuric acid, trifluoroacetic acid, p-toluenesulfonic acid, and methanesulfonic acid, and the reaction solvent is one or a mixture of xylene, toluene, chlorobenzene, carbon tetrachloride, N,N-dimethylformamide, and dimethyl sulfoxide.
[0021] Compared with the prior art, the present invention has the following beneficial effects:
[0022] 1. The present invention adopts a three-step synthesis process of hydrogenation reduction reaction-amine ester exchange reaction-cyclization reaction to prepare compound V, which can effectively simplify the synthesis process of pyrimidinedione compounds, greatly shorten the synthesis route of pyrimidinedione compound V, and then use low-priced and easily available benzonitriles (i.e., compound I) as starting materials, effectively reducing the cost of preparation, and utilizing the acidic effect of anhydrous acid to make intermediate IV undergo cyclization reaction under the catalysis of anhydrous acid, effectively inhibiting the generation of V-impurity impurities, effectively reducing the generation of reaction by-products, thereby ensuring the purification of pyrimidinedione compound V, and also effectively improving the yield, making the preparation process of pyrimidinedione compound V more environmentally friendly and meeting the requirements of industrial production.
[0023] 2. The present invention uses the easily available and inexpensive compound I to carry out the hydrogenation reduction reaction, so that the preparation of the intermediate II is more convenient and quick. The intermediate II is used to carry out the amine ester exchange reaction with the compound III, so that the intermediate IV is effectively purified, and the generation of IV-impurity impurities is effectively avoided. Then, the acidic effect of anhydrous acid is used to make the intermediate IV undergo a cyclization reaction under the acidic effect, which effectively inhibits the generation of V-impurity impurities and effectively reduces the generation of reaction by-products, thereby ensuring the purification of the pyrimidinedione compound V. At the same time, the yield is also effectively improved, making the preparation process of the pyrimidinedione compound V more environmentally friendly and meeting the requirements of industrial production.
[0024] 3. The present invention utilizes the mutual synthesis between compound I, intermediate II, compound III and intermediate IV to shorten the synthesis route of pyrimidinedione compound V, effectively simplify the synthesis process of pyrimidinedione compound V, and thus effectively reduce the cost of preparing pyrimidinedione compound V. DETAILED DESCRIPTION
[0025] The following examples are used to further illustrate the content of the present invention, but do not limit the application of the present invention.
[0026] Example 1
[0027] Step 1, (Preparation of Intermediate II):
[0028] First, 2-fluoro-6-(trifluoromethyl)benzonitrile is used as compound I as the starting reaction raw material, Ranney-Ni is used as a metal catalyst, and hydrogen is used as a reducing agent; ethanol is selected as an organic solvent;
[0029] Compound I (20 g, 106 mmol), ethanol (100 mL), Ranney-Ni (2 g) and ammonia water (4 g) were added to a miniature hydrogenation reactor equipped with a thermometer, a stirrer and a pressure gauge, stirred and dissolved, and replaced with hydrogen. At the same time, the temperature was raised to 45-55°C, and the hydrogen pressure was adjusted to 0.1-0.5 MPa for 7-8 hours of hydrogenation reduction reaction. The reaction of compound I was tracked according to HPLC (high performance liquid chromatography) until the reaction was complete. After the reaction was completed, Ranney-Ni was filtered out and the filtrate was concentrated to obtain 2-fluoro-6-trifluoromethylbenzylamine (intermediate II) (21 g, molar yield was 100%, purity was 97%).
[0030] Step 2, (Preparation of Intermediate IV):
[0031] First, 2-fluoro-6-(trifluoromethyl)benzonitrile is used as compound I for hydrogenation reduction reaction to obtain 2-fluoro-6-trifluoromethylbenzylamine (intermediate II) as the reaction starting material of intermediate IV, and (3-oxobutyl)-ethyl carbamate is used as compound III as the reaction raw material, and then tetrahydrofuran is selected as the furan solvent, and sodium ethoxide is selected as the strong base weak acid salt organic base;
[0032] Then, intermediate II (21 g, 108 mmol), tetrahydrofuran (200 ml) and compound III (21 g, 122 mmol) were added to a four-necked reaction bottle equipped with a thermometer and a stirrer, stirred and dissolved, and sodium ethoxide (6 g, 88 mmol) was added at 25-30°C, and then the temperature was raised to 60-70°C for 5-8 hours of amine ester exchange reaction, and the reaction of intermediate II was tracked according to HPLC (high performance liquid chromatography) until the reaction was complete. After the reaction was completed, the mixture was washed with water, concentrated, and slurried with ethanol to obtain N-((2-fluoro-6-trifluoromethylphenyl)carbamoyl)-3-oxobutanamide (intermediate IV) (30 g, molar yield was 88%, purity was 98%).
[0033] Step 3, (Preparation of Compound V):
[0034] First, N-((2-fluoro-6-trifluoromethylphenyl)carbamoyl)-3-oxobutanamide (intermediate IV) obtained in step 2 is used as the starting material for the reaction of compound V, and p-toluenesulfonic acid is selected as the anhydrous acid and toluene is selected as the reaction solvent;
[0035] Then, in a four-necked reaction flask equipped with a thermometer and a stirrer, the intermediate IV (30 g, 95 mmol) and toluene (200 ml) were stirred and dissolved, and then p-toluenesulfonic acid (31 g, 180 mmol) was added to the four-necked reaction flask for stirring and reflux with water, and the temperature was raised to 80-100° C. for 2-3 hours of cyclization reaction. After the reaction, the temperature was lowered to room temperature, washed with 2M sodium hydroxide and water until neutral, concentrated and then purified with isopropanol to obtain the target compound 1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione (Compound V) (25.5 g, molar yield of 91%, purity of 99.8%).
[0036] Embodiment 2:
[0037] Step 1, (Preparation of Intermediate II):
[0038] First, 2,4,6-trifluorobenzonitrile is used as compound I as the starting reaction raw material, Ranney-Ni is used as a metal catalyst, and hydrogen is used as a reducing agent; and ethanol is selected as an organic solvent;
[0039] Compound I (20 g, 127 mmol), ethanol (100 mL), Ranney-Ni (2 g) and ammonia water (4 g) were added to a miniature hydrogenation reactor equipped with a thermometer, a stirrer and a pressure gauge, stirred and dissolved, and replaced with hydrogen. At the same time, the temperature was raised to 45-55°C, and the hydrogen pressure was adjusted to 0.1-0.5 MPa for 7-8 hours of hydrogenation reduction reaction. The reaction of compound I was tracked according to HPLC (high performance liquid chromatography) until the reaction was complete. After the reaction was completed, Ranney-Ni was filtered out and the filtrate was concentrated to obtain 2,4,6-trifluoromethylbenzylamine (intermediate II) (20.5 g, molar yield was 100%, purity was 95%).
[0040] Step 2, (Preparation of Intermediate IV):
[0041] First, 2,4,6-trifluorobenzonitrile is used as compound I for hydrogenation reduction reaction to obtain 2,4,6-trifluoromethylbenzylamine (intermediate II) as the reaction starting material of intermediate IV, and (3-oxobutyl)-ethyl carbamate is used as compound III as the reaction raw material, and then tetrahydrofuran is selected as the furan solvent, and sodium ethoxide is selected as the strong base weak acid salt organic base;
[0042] Then, intermediate II (20.5 g, 127 mmol), tetrahydrofuran (200 ml) and compound III (21 g, 122 mmol) were added to a four-necked reaction bottle equipped with a thermometer and a stirrer for stirring and dissolving, and sodium ethoxide (6 g, 88 mmol) was added at 25-30°C, and then the temperature was raised to 60-70°C for 5-8 hours of amine ester exchange reaction, and the reaction of intermediate II was tracked according to HPLC (high performance liquid chromatography) until the reaction was complete. After the reaction was completed, the mixture was washed with water, concentrated, and slurried with ethanol to obtain N-((2,4,6-trifluoromethylphenyl)carbamoyl)-3-oxobutanamide (intermediate IV) (31 g, molar yield of 85%, purity of 98%).
[0043] Step 3, (Preparation of Compound V):
[0044] First, N-((2,4,6-trifluoromethylphenyl)carbamoyl)-3-oxobutanamide (intermediate IV) obtained in step 2 is used as the starting material for the reaction of compound V, and p-toluenesulfonic acid is selected as the anhydrous acid and toluene is selected as the reaction solvent;
[0045] Then, in a four-necked reaction flask equipped with a thermometer and a stirrer, the intermediate IV (31 g, 108 mmol) and toluene (200 ml) were stirred and dissolved, and then p-toluenesulfonic acid (31 g, 180 mmol) was added to the four-necked reaction flask, stirred and refluxed with water, and the temperature was raised to 80-100° C. for 2-3 hours of cyclization reaction. After the reaction, the temperature was lowered to room temperature, washed with 2M sodium hydroxide and water until neutral, concentrated and then purified with isopropanol to obtain the target compound 1-(2,4,6-trifluoromethylbenzyl)-6-methylpyrimidine-2,4(1H,3H)-dione (Compound V) (25 g, molar yield of 88%, purity of 99.8%).
[0046] Embodiment 3:
[0047] Step 1, (Preparation of Intermediate II):
[0048] First, 2,6-dichlorobenzonitrile is used as compound I as the starting reaction raw material, Ranney-Ni is used as a metal catalyst, and hydrogen is used as a reducing agent; and ethanol is selected as an organic solvent;
[0049] Compound I (20 g, 116 mmol), ethanol (100 mL), Ranney-Ni (2 g) and ammonia water (4 g) were added to a miniature hydrogenation reactor equipped with a thermometer, a stirrer and a pressure gauge, stirred and dissolved, and replaced with hydrogen. At the same time, the temperature was raised to 45-55°C, and the pressure of hydrogen was adjusted to 0.1-0.5 MPa for 7-8 hours of hydrogenation reduction reaction. The reaction of compound I was tracked according to HPLC (high performance liquid chromatography) until the reaction was complete. After the reaction was completed, Ranney-Ni was filtered out, and the filtrate was concentrated to obtain 2,6-dichloromethylbenzylamine (intermediate II) (20.5 g, molar yield was 100%, purity was 95%).
[0050] Step 2, (Preparation of Intermediate IV):
[0051] First, 2,6-dichlorobenzonitrile is used as compound I for hydrogenation reduction reaction to obtain 2,6-dichloromethylbenzylamine (intermediate II) as the reaction starting material of intermediate IV, and (3-oxobutyl)-ethyl carbamate is used as compound III as the reaction raw material, and then tetrahydrofuran is selected as the furan solvent, and sodium ethoxide is selected as the strong base weak acid salt organic base;
[0052] Then, intermediate II (20.5 g, 116 mmol), tetrahydrofuran (200 ml) and compound III (21 g, 122 mmol) were added to a four-necked reaction bottle equipped with a thermometer and a stirrer for stirring and dissolving, and sodium ethoxide (6 g, 88 mmol) was added at 25-30°C, and then the temperature was raised to 60-70°C for 5-8 hours of amine ester exchange reaction, and the reaction of intermediate II was tracked according to HPLC (high performance liquid chromatography) until the reaction was complete. After the reaction was completed, the mixture was washed with water, concentrated, and slurried with ethanol to obtain N-((2,6-dichloromethylphenyl)carbamoyl)-3-oxobutanamide (intermediate IV) (30 g, molar yield was 83%, purity was 96%).
[0053] Step 3, (Preparation of Compound V):
[0054] First, N-((2,6-dichloromethylphenyl)carbamoyl)-3-oxobutanamide (intermediate IV) obtained in step 2 is used as the starting material for the reaction of compound V, and p-toluenesulfonic acid is selected as the anhydrous acid and toluene is selected as the reaction solvent;
[0055] Then, in a four-necked reaction flask equipped with a thermometer and a stirrer, the intermediate IV (30 g, 99 mmol) and toluene (200 ml) were stirred and dissolved, and then p-toluenesulfonic acid (31 g, 180 mmol) was added to the four-necked reaction flask for stirring and reflux with water, and the temperature was raised to 80-100° C. for 2-3 hours of cyclization reaction. After the reaction, the temperature was lowered to room temperature, washed with 2M sodium hydroxide and water until neutral, concentrated and then purified with isopropanol to obtain the target compound 1-(2,6-dichloromethylbenzyl)-6-methylpyrimidine-2,4(1H,3H)-dione (Compound V) (23 g, molar yield of 84%, purity of 99.7%).
[0056] Comparative Example 1:
[0057] Step 1, (Preparation of Intermediate II):
[0058] First, 2-fluoro-6-(trifluoromethyl)benzonitrile is used as compound I as the starting reaction raw material, concentrated hydrochloric acid is used as a common catalyst, Zn (zinc) or HCL (hydrogen chloride) is used as a reducing agent; and 1,4-dioxane is selected as an organic solvent;
[0059] Compound I (20 g, 106 mmol), 1,4-dioxane (100 mL) and concentrated hydrochloric acid (20 ml) were added to a miniature hydrogenation reactor equipped with a thermometer, a stirrer and a pressure gauge for stirring and dissolving. Zn powder or HCL was added in batches at 10-20° C. After the addition, the temperature was raised to 45-55° C. for 7-8 hours of hydrogenation reduction reaction, and the reaction of compound I was tracked according to HPLC (high performance liquid chromatography) until the reaction was complete. After the reaction was completed, Ranney-Ni was filtered out and the filtrate was concentrated to obtain 2-fluoro-6-trifluoromethylbenzylamine (intermediate II) (16 g, molar yield was 80%, purity was 92%).
[0060] Step 2, (Preparation of Intermediate IV):
[0061] First, 2-fluoro-6-(trifluoromethyl)benzonitrile is used as compound I for hydrogenation reduction reaction to obtain 2-fluoro-6-trifluoromethylbenzylamine (intermediate II) as the reaction starting material of intermediate IV, and (3-oxobutyl)-ethyl carbamate is used as compound III as the reaction raw material, and then tetrahydrofuran is selected as the furan solvent, and sodium ethoxide is selected as the strong base weak acid salt organic base;
[0062] Then, intermediate II (16 g, 84 mmol), tetrahydrofuran (200 ml) and compound III (16 g, 92 mmol) were added to a four-necked reaction bottle equipped with a thermometer and a stirrer, stirred and dissolved, and sodium ethoxide (6 g, 88 mmol) was added at 25-30°C, and then the temperature was raised to 60-70°C for 5-8 hours of amine ester exchange reaction, and the reaction of intermediate II was tracked according to HPLC (high performance liquid chromatography) until the reaction was complete. After the reaction was completed, the mixture was washed with water, concentrated, and slurried with ethanol to obtain N-((2-fluoro-6-trifluoromethylphenyl)carbamoyl)-3-oxobutanamide (intermediate IV) (23 g, molar yield of 88%, purity of 95%).
[0063] Step 3, (Preparation of Compound V):
[0064] First, N-((2-fluoro-6-trifluoromethylphenyl)carbamoyl)-3-oxobutanamide (intermediate IV) obtained in step 2 is used as the starting material for the reaction of compound V, and p-toluenesulfonic acid is selected as the anhydrous acid and toluene is selected as the reaction solvent;
[0065] Then, in a four-necked reaction flask equipped with a thermometer and a stirrer, the intermediate IV (23 g, 73 mmol) and toluene (200 ml) were stirred and dissolved, and then p-toluenesulfonic acid (23 g, 133 mmol) was added to the four-necked reaction flask for stirring and reflux with water, and the temperature was raised to 80-100° C. for 2-3 hours of cyclization reaction. After the reaction, the temperature was lowered to room temperature, washed with 2M sodium hydroxide and water until neutral, concentrated and then purified with isopropanol to obtain the target compound 1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione (Compound V) (15 g, molar yield of 66%, purity of 97%).
[0066] The following is a parameter comparison table of compound V prepared in Examples 1 to 3 and compound V prepared in Comparative Example 1:
[0067] ,
[0068] As can be seen from the above table, compound I is 2-fluoro-6-(trifluoromethyl)benzonitrile and 2,4,6-trifluorobenzonitrile, and the compound V content synthesized under metal catalyst and hydrogen reduction is higher and the V-impurity content is lower. The total yield of the former is higher than that of the latter. The compound V synthesized under 2-fluoro-6-(trifluoromethyl)benzonitrile under ordinary catalyst and Zn powder or HCL reduction has a lower content, a higher V-impurity content and a lower total yield. It can be seen that the content of compound V, the V-impurity content and the total yield are related to the selection of catalyst and reducing agent.
Claims
1. A method for preparing a synthetic pyrimidinedione compound, characterized in that: The specific synthetic route is as follows: ; Among them, compound I is used as a raw material to undergo a hydrogenation reduction reaction under the action of a metal catalyst to obtain intermediate II, intermediate II and compound III undergo an amine ester exchange reaction to achieve the preparation of intermediate IV, and intermediate IV undergoes a cyclization reaction under anhydrous acid conditions to achieve the preparation of target compound V; The specific synthesis steps are as follows: S1. Preparation of intermediate II: Compound I is used as a starting material for the reaction, and is directly put into a hydrogenation reactor, and a hydrogenation reduction reaction is carried out in an atmosphere of an organic solvent and a reducing agent under the action of a metal catalyst and ammonia water, and the intermediate II is obtained by treatment and concentration, wherein the amount of the metal catalyst is 0.1 to 20% by weight of compound I, and the metal catalyst is Ranney-Ni; compound I is one of benzonitrile, 2,4,6-trifluorobenzonitrile, 2-fluoro-6-(trifluoromethyl)benzonitrile, 2-fluoro-6-chlorobenzonitrile, p-cyanotoluene, 2,6-dichlorobenzonitrile, and 5-bromo-2-(trifluoromethoxy)benzonitrile; S2. Preparation of intermediate IV: Intermediate II obtained in S1 is mixed with compound III in a furan solvent, strong base and weak acid salt organic base are added at room temperature, amine ester exchange reaction is carried out at 0-70°C, concentrated, washed with water, and then slurried with ethanol to obtain intermediate IV, wherein the molar ratio of intermediate II to compound III is 1:1.0-6.0, compound III is one of (3-oxobutyl)-ethyl carbamate, (3-oxobutyl)-methyl carbamate, and 2,4-dioxopiperidine-1-carboxylic acid benzyl ester, the furan solvent is one of dimethylformamide, dimethyl sulfoxide, tetrahydrofuran, acetonitrile, 1,4-dioxane, and dimethylacetamide, or a mixture of several thereof, and the strong base and weak acid salt organic base is one of sodium methoxide, sodium ethoxide, and sodium hydride; S3. Preparation of compound V: The intermediate IV obtained in S2 is stirred in a reaction solvent, and refluxed with water under anhydrous acid conditions, and a cyclization reaction is carried out at 20-150°C for 1-10 hours, and then purified with isopropanol to obtain the target compound V, wherein the molar ratio of the intermediate IV to the anhydrous acid is 1:0.1-3.0, and the anhydrous acid is one or a mixture of thionyl chloride, glacial acetic acid, nitric acid, sulfuric acid, trifluoroacetic acid, p-toluenesulfonic acid, and methanesulfonic acid.
2. The method for preparing a synthetic pyrimidinedione compound according to claim 1, characterized in that: In S1, the organic solvent is one of methanol, ethanol, tetrahydrofuran, N,N-dimethylacetamide, acetone, acetonitrile, ethylene glycol, dimethyl sulfoxide, 1,4-dioxane, or a mixture thereof; the reducing agent is one of H2, NaBH4, NaBH3CN, Zn or HCL.
3. The method for preparing a synthetic pyrimidinedione compound according to claim 1, characterized in that: In S1, the temperature of the hydrogenation reduction reaction is 20 to 100°C, and the pressure of the hydrogenation reduction reaction is 0.1 to 2 MPa.
4. The method for preparing a synthetic pyrimidinedione compound according to claim 1, characterized in that: In S3, the reaction solvent is one or a mixture of xylene, toluene, chlorobenzene, carbon tetrachloride, N,N-dimethylformamide, and dimethyl sulfoxide.
